EL7.AI
Strategy BuilderCOT DataAdvanced NewsResearchNewEarnings CalendarEconomic Calendar
We use cookiesPrivacy Policy
EL7.AIEL7.AI

AI Financial Intelligence
Professional analysis of central bank decisions

© 2026 EL7.AI. All rights reserved.

Markets

  • News
  • Forex
  • Stocks
  • Crypto
  • Gold
  • Commodities
  • Indices
  • ETFs

Analysis

  • Fed
  • ECB
  • BLS
  • COT
  • Economic Calendar

Learn

  • Service Guide
  • Oil

Company

  • About
  • Contact
  • Data Methodology
  • AI Disclosure
  • Pricing
  • Enterprise
  • Terms
  • Privacy
  • Security
  • WhatsApp
Status data is currently unavailable

The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Home
Stocks
Rallybio Corporation
RLYB

RLYB Rallybio Corporation

Rallybio Corporation · NASDAQ
Market Open
17.19
▲ ⁦+0.17%⁩ (+0.03)
Market Cap$91.2M
Beta-0.86
52w Low52w High
3.6717.57
Last Week
⁦+1.84%⁩
Last Month
⁦+1.12%⁩
Last 3 Months
⁦+8.05%⁩
Last Year
⁦+252.98%⁩
EL7 Factor Analysis
How we score this
Overall38
Weak — below market medianSuper StockF 5/9Better than 38% of Market stocks, per EL7's model
FactorScoreDistributionValueAvgRank
▸
Valuation
86
2.6x▲17.6xTop tier
▸
Growth
42
—7.1%Around median
▸
Quality
59
-41.3%▼4.5%Around median
▸
Safety
97
—2.6xTop tier
▸
Capital Return
47
—2.15%Around median
▸
Momentum
99
249.1%▲2.3%Top tier
▸
Sentiment
23
1▼3Bottom tier

Frequently Asked Questions

What is Rallybio Corporation stock?▼

Rallybio Corporation is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.

How can I invest in Rallybio Corporation?▼

You can buy Rallybio Corporation shares through a licensed brokerage. Research the company's financials before investing.

What are the key metrics for evaluating Rallybio Corporation?▼

Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.

Does Rallybio Corporation pay dividends?▼

Dividend policies vary by company. Check the dividends section on the stock page for the payout history.

What are the risks of investing in Rallybio Corporation?▼

Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.

Fair Value
Low confidenceCurrent price$17
Analyst target
No data
vs
DCF (estimate)
$99
⁦+475%⁩
Sees it clearly undervalued
⁦7.9⁩% discount · ⁦0⁩% growth

Estimates — analyst targets and a simplified DCF, not investment advice.

Compare in the screener

AI analysis from the earnings call, financials and news

Analyst Consensus

This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.

Price Target
—
Current Price $17.19
Average rating
★ 3.00
Hold
Analyst coverage
1
Buy conviction
0%
Analyst ratings over time1 analysts rating
1
Strong BuyBuyHoldSellStrong Sell
Rating trend — last 12 months3.00 → 3.00
Recent analyst moves
  • = Reiterate2024-10-01
    H.C. Wainwright
    Buy
  • = Reiterate2024-09-03
    H.C. Wainwright
    Buy
  • = Reiterate2022-02-22
    JMP Securities
    Market Outperform
Premium content
Key Financials

Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.

StockSector medianSector averagetypical sector range
MetricValuePosition within sectorVerdict
  • P/E (TTM)
    2.64x
    3.68x44.95x
    Very cheap
  • Forward P/E
    —
    —
  • EV / EBITDA
    0.30x
    3.78x30.25x
    Very cheap
  • FCF Yield
    26.4%
    -145.2%7.8%
    Exceptional
  • Revenue Growth YoY
    —
    —
  • EPS Growth YoY
    155.8%
    -159.3%129.8%
    Exceptional
  • Gross Margin
    —
    —
  • ROIC
    -41.3%
    -154.2%16.1%
    Above average
  • Net Debt / EBITDA
    —
    —
  • Dividend Yield
    —
    —
  • Payout Ratio
    —
    —
  • Altman Z-Score
    —
    —
Financial Analysis
|